Here are four more updates: Influenza activity remained elevated but has been declining for four consecutive weeks. Flu-related emergency department visits remain moderate, and test positivity is at 16.1%.

The U.S. Food and Drug Administration (FDA) has issued its recommendations to vaccine makers on which virus strains to select when manufacturing influenza (flu) vaccines for the 2025-2026 U.S. flu season.